Has Syeda Atiqa Batul, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,984 in general payments to Syeda Atiqa Batul, MD across 150 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Syeda Atiqa Batul, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Syeda Atiqa Batul, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Syeda Atiqa Batul, MD

Cardiovascular Disease · Scranton, PANPI 1326384868

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 78.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $7,616 and has fallen 76.6% since, to $1,778 in 2025. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,984in general payments, 2019–2025

Across 150 payments — averaging $139.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$16K
Medical Device Business Services, Inc.$1K
Boston Scientific$1K
Abbott$796
Biosense Webster, Inc.$712
Philips North America LLC$391
plus $287 from 3 others

What the payments were for

Consulting fees$1,1005%
Speaking & faculty fees$5,91328%
Travel & lodging$8,88942%
Food & beverage$4,61722%
Education$4642%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	78	$16,466
Medical Device Business Services, Inc.	5	$1,264
Boston Scientific	36	$1,067
Abbott	13	$796
Biosense Webster, Inc.	11	$712
Philips North America LLC	2	$391
Biotronik Inc.	3	$220
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$47
Cordis US CORP.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,984 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.

See all cardiovascular disease providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$182,744

Medicare patients

895

Services billed

3,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	89	$72,241
Metoprolol Succinate	260	$5,854
Flecainide Acetate	37	$1,027
Diltiazem 24hr Er (Cd)Diltiazem Hcl	21	$919
Amiodarone Hcl	45	$612
Metoprolol Tartrate	30	$323
Warfarin Sodium	27	$250
Atorvastatin Calcium	15	$219
Amlodipine Besylate	32	$149
Pantoprazole Sodium	11	$147
ClopidogrelClopidogrel Bisulfate	13	$145
Losartan Potassium	12	$133
Furosemide	13	$114

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Scranton

Michael KayalScranton$124K
Stephen VoyceScranton$81K
Hemal GadaWormleysburg$1.8M
Benjamin KalsmithPgh$1.7M
Peter KoweyWynnewood$1.5M
Paul ForfiaPhiladelphia$1.2M
Quang BuiPhiladelphia$933K
Rhian DaviesYork$853K
Sarang MangalmurtiBryn Mawr$728K
Sabahat BokhariAllentown$578K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →